[
  {
    "ts": "2025-12-04T12:39:00+00:00",
    "headline": "How Strong Is AbbVie's Immunology Franchise After Humira's LOE?",
    "summary": "ABBV rebounds after Humira's LOE as soaring Skyrizi and Rinvoq sales drive a powerful immunology comeback.",
    "url": "https://finance.yahoo.com/news/strong-abbvies-immunology-franchise-humiras-123900413.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "2e332b71-3833-3572-a4df-6abc427e0a3e",
      "content": {
        "id": "2e332b71-3833-3572-a4df-6abc427e0a3e",
        "contentType": "STORY",
        "title": "How Strong Is AbbVie's Immunology Franchise After Humira's LOE?",
        "description": "",
        "summary": "ABBV rebounds after Humira's LOE as soaring Skyrizi and Rinvoq sales drive a powerful immunology comeback.",
        "pubDate": "2025-12-04T12:39:00Z",
        "displayTime": "2025-12-04T12:39:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/dbd916198e87314e1ef238f8179e6227",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/OQG3.5Wd9P9R69q2rhm9rA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/dbd916198e87314e1ef238f8179e6227.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/pBlncPVBhEXpjxtBDlEOsg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/dbd916198e87314e1ef238f8179e6227.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/strong-abbvies-immunology-franchise-humiras-123900413.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/strong-abbvies-immunology-franchise-humiras-123900413.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-04T08:00:00+00:00",
    "headline": "BeOne brought Brukinsa to the blood cancer mountaintop. Can it hit those heights again?",
    "summary": "The company’s chief medical officer discusses its trajectory with the blockbuster Brukinsa and its strong hematology pipeline.",
    "url": "https://www.pharmavoice.com/news/beone-blood-cancer-brukinsa-sonrotoclax-leukemia-lymphoma/807019/",
    "source": "Pharma Voice",
    "provider": "yfinance",
    "raw": {
      "id": "23bb2376-e22c-3722-a890-f4c363360351",
      "content": {
        "id": "23bb2376-e22c-3722-a890-f4c363360351",
        "contentType": "STORY",
        "title": "BeOne brought Brukinsa to the blood cancer mountaintop. Can it hit those heights again?",
        "description": "",
        "summary": "The company’s chief medical officer discusses its trajectory with the blockbuster Brukinsa and its strong hematology pipeline.",
        "pubDate": "2025-12-04T08:00:00Z",
        "displayTime": "2025-12-04T08:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/pharma_voice_330/ebe272ab58bd5f4860f49994e2412f2a",
          "originalWidth": 1280,
          "originalHeight": 720,
          "caption": "PharmaVoice, an Industry Dive publication",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/faCzssBpuaIVME6M0juLqw--~B/aD03MjA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/pharma_voice_330/ebe272ab58bd5f4860f49994e2412f2a.cf.webp",
              "width": 1280,
              "height": 720,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/CqL3QO_OKFjlEPfzRSbRjg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/pharma_voice_330/ebe272ab58bd5f4860f49994e2412f2a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Pharma Voice",
          "url": "https://www.pharmavoice.com/"
        },
        "canonicalUrl": {
          "url": "https://www.pharmavoice.com/news/beone-blood-cancer-brukinsa-sonrotoclax-leukemia-lymphoma/807019/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/beone-brought-brukinsa-blood-cancer-080000107.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "AZN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-04T14:27:00+00:00",
    "headline": "3 Large Drug Stocks to Watch as the Industry Shows Some Recovery",
    "summary": "In the Large-Cap Pharmaceuticals industry, Lilly, J&J and Sanofi are worth retaining as the industry shows some recovery.",
    "url": "https://finance.yahoo.com/news/3-large-drug-stocks-watch-142700725.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "18569e85-7832-39f7-8e4b-10938849c2b4",
      "content": {
        "id": "18569e85-7832-39f7-8e4b-10938849c2b4",
        "contentType": "STORY",
        "title": "3 Large Drug Stocks to Watch as the Industry Shows Some Recovery",
        "description": "",
        "summary": "In the Large-Cap Pharmaceuticals industry, Lilly, J&J and Sanofi are worth retaining as the industry shows some recovery.",
        "pubDate": "2025-12-04T14:27:00Z",
        "displayTime": "2025-12-04T14:27:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/5d5a6eb884ce28277f39a4369974b5ea",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/.Z6CaNjdpI8OLeo5.Ul_eA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/5d5a6eb884ce28277f39a4369974b5ea.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/o6kyOwY40meLORq99yf8XA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/5d5a6eb884ce28277f39a4369974b5ea.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/3-large-drug-stocks-watch-142700725.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/3-large-drug-stocks-watch-142700725.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "AZN"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "NVO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-04T16:20:00+00:00",
    "headline": "Can Merck's New Products Aid Growth as Keytruda LOE Test Looms?",
    "summary": "MRK banks on Capvaxive, Winrevair and other new launches to counter Keytruda's looming 2028 LOE and record long-term growth.",
    "url": "https://finance.yahoo.com/news/mercks-products-aid-growth-keytruda-162000136.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "802086c1-cf2d-37e7-9e26-f936354f22ea",
      "content": {
        "id": "802086c1-cf2d-37e7-9e26-f936354f22ea",
        "contentType": "STORY",
        "title": "Can Merck's New Products Aid Growth as Keytruda LOE Test Looms?",
        "description": "",
        "summary": "MRK banks on Capvaxive, Winrevair and other new launches to counter Keytruda's looming 2028 LOE and record long-term growth.",
        "pubDate": "2025-12-04T16:20:00Z",
        "displayTime": "2025-12-04T16:20:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/df847a6f57145ec8b42be7c65f980057",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/EfDoN3QVRYGCfRDweFAACw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/df847a6f57145ec8b42be7c65f980057.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/JwDxubmjtiCRyiYBqVh9AQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/df847a6f57145ec8b42be7c65f980057.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/mercks-products-aid-growth-keytruda-162000136.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/mercks-products-aid-growth-keytruda-162000136.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRK"
            },
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-04T19:02:55+00:00",
    "headline": "How Stock Of The Day Genmab Is Leveraging An $8 Billion Deal To Stoke Its Next Chapter",
    "summary": "Genmab stock, Thursday's IBD Stock Of The Day, is just below an early entry in a cup case after announcing an $8 billion deal to buy Merus.",
    "url": "https://www.investors.com/news/technology/genmab-stock-merus-takeover-adcs/?src=A00220&yptr=yahoo",
    "source": "Investor's Business Daily",
    "provider": "yfinance",
    "raw": {
      "id": "3b477a06-ec08-3db4-ab9a-89c6fe532333",
      "content": {
        "id": "3b477a06-ec08-3db4-ab9a-89c6fe532333",
        "contentType": "STORY",
        "title": "How Stock Of The Day Genmab Is Leveraging An $8 Billion Deal To Stoke Its Next Chapter",
        "description": "",
        "summary": "Genmab stock, Thursday's IBD Stock Of The Day, is just below an early entry in a cup case after announcing an $8 billion deal to buy Merus.",
        "pubDate": "2025-12-04T19:02:55Z",
        "displayTime": "2025-12-04T19:02:55Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/3b477a06-ec08-3db4-ab9a-89c6fe532333/how-stock-of-the-day-genmab.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/ibd.com/fd63600ecbce3ce895aba09f4a45aedf",
          "originalWidth": 816,
          "originalHeight": 430,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/cnl3Gmev839TziJivJyNyw--~B/aD00MzA7dz04MTY7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/fd63600ecbce3ce895aba09f4a45aedf.cf.webp",
              "width": 816,
              "height": 430,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/AIXdROiRkvuhiitwJBJpdw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/fd63600ecbce3ce895aba09f4a45aedf.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Investor's Business Daily",
          "url": "http://www.investors.com/"
        },
        "canonicalUrl": {
          "url": "https://www.investors.com/news/technology/genmab-stock-merus-takeover-adcs/?src=A00220&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GMAB"
            },
            {
              "symbol": "MRUS"
            },
            {
              "symbol": "GNMSF"
            },
            {
              "symbol": "NVS"
            },
            {
              "symbol": "NVSEF"
            },
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]